14
Views
8
CrossRef citations to date
0
Altmetric
Original Article

Histological Characteristics of Lupus Nephritis in Fl Mice With Chronic Graft-Versus-Host Reaction Across MHC Class II Difference

, , , , , & show all
Pages 79-87 | Received 27 Sep 1991, Accepted 12 Dec 1991, Published online: 07 Jul 2009

References

  • Howie J. B., Helyer B. J. The immunology and pathology of NZB mice. Advan Immunol 1968; 9: 215–266
  • Talal N., Steinberg A. D. The pathogenesis of autoimmunity in NZB mice. Curr top Microbiol Immunol 1974; 64: 79–103
  • Andrews B. S., Eisenberg R. A., Theofilopoulos A. N., Izui S., Wilson C. B., McConahey P. J., Murphy E. D., Roths J. B., Dixon F. J. Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains. J Exp Med 1978; 148: 1198–1215
  • Izui S., Lambert P. H., Fournie G. J., Turler H., Miescher P. Features of systemic lupus erythematosus in mice injected with bacterial lipipolysaccharides. Identification of circulating DNA and renal localization of DNA-anti-DNA complexes. J Exp Med 1977; 145: 1115–1130
  • Gleichmann H., Gleichmann E., Schwartz J. A., Schwartz R. S. Chronic allogeneic disease. III. Genetic requirements for the induction of glomerulonephritis. J Exp Med 1972; 135: 516–532
  • Gleichmann E., Van Elven E. H., Van der Veer P. W. A systemic lupus erythematosus (SLE)-like disease in mice induced by abnormal T-B cell cooperation. Preferential formation of autoantibodies characteristic of SLE. Eur J Immunol 1982; 12: 152–159
  • Rolink A. G., Gleichmann H., Gleichmann E. Diseases caused by reactions of T lymphocytes to incompatible structures of the major histocompatibility complex. VII. Immune-Complex Glomerulonephritis. J Immunol 1983; 130: 209–215
  • Brujin J. A., Van Elven E. H., Hogendoon P. C. W., Corver W. E., Hoedemaeker P. J., Fleuren G. J. Murine chronic graft-versus-host disease as a model for lupus nephritis. Am J Pathol 1988; 46: 387–407
  • Rolink A. G., Pals S. T., Gleichmann Allosuppressor E., Allohelper T. cells in acute and chronic graft-vs-host disease. II. Fl recipients carrying mutations at H-2K and/or I. -A. J Exp Med 1983; 157: 755–771
  • Saitoh T., Fujiwara M., Nomoto M., Makino M., Watanabe H., Ishihara K., Kamimura T., Ichida F. Hepatic lesions induced by graft-versus-host reaction across MHC class II antigens: An implication for animal model of primary biliary cirrhosis. Clin Immunol Immunopath 1988; 49: 166–172
  • Via C. S., Shearer G. M. T-cell interactions in autoimmunity: insights from a murine model of graft-versus-host disease. Immunol Today 1988; 9: 207–213
  • Rolink A. G., Randaszkiewicz T., Pals S. T., van der Meer W. G. T., Gleichmann Allosuppressor E., Allohelper T. cells in acute and chronic graft-vs.-host disease. I. Alloreactive suppressor cells rather than killer T cells appear to be the decisive effector cells in lethal graft-vs.-host disease. J Exp Med 1982; 155: 1501–1522
  • Rolink A. G., Gleichmann E. Allosuppressor and allohelper T cells in acute and chronic graft-vs.-host disease. III. Different Lyt subsets of donor T cells induce different pathological syndromes. J Exp Med 1983; 158: 546–558
  • Gleichmann E., Pals S. T., Rolink A. G., Radaskiewicz T., Gleichmann H. Graft-versus-host reactions: clues to the etiopathology of a spectrum of immunological diseases. Immunol Today 1984; 5: 324–332
  • McKenzie I. F. C., Morgan G. M., Sandrin M. S., Michaelides M. M., Mellvold R. W., Kohn H. I. B6.C-Hb2. A new H-2 mutation in the I region in the mouse. J Exp Med 1983; 157: 755–771
  • Baily D. L., Snell G. D., Cherry M. Complementation and serological analysis of an H-2 mutant. Immunogenetics of H-2 system, A. Lengerova, M. Bojtiskova. S. Karger, Basel 1971; 155
  • Shiraki M., Fujiwara M., Tomura S. Long term administration of cyclophosphamide in MRL/1 mice. I. The effects on the development of immunological abnormalities and lupus nephritis. Clin Exp Immunol 1984; 55: 333–339
  • Makino M., Fujiwara M., Watanabe H. Studies on the mechanisms of the development of lupus nephritis in BXSB mice. I. Analyses of immunological abnormalities at the onset period. J Clin Lab Immunol 1987; 22: 127–131
  • Makino M., Fujiwara M., Watanabe H., Sugano H., Arakawa M. Evaluation of different preparations of aggregated human IgG for use as a standard in the assays of circulating immune complexes. J Clin Lab Immunol 1986; 21: 151–157
  • Kolb W. P., Kolb L. M., Podack E. R. Clq isolation from human serum in high yield by affinity chromatography and development of a highly sensitive hemolytic assay. Immunol 1979; 122: 2103–2111
  • Gronowicz E., Countinho A., Mechers F. A plaque assay for all cells secreting Ig of a given type or class. Eur J Immunol 1976; 6: 588–590
  • Makino M., Fujiwara M., Aoyagi T., Umezawa H. Immunosup pressive activities of deoxyspergualin. I. Effect of the long-term administration of the drug on the development of murine lupus. Immunopharmacology 1987; 14: 107–114
  • Ishikawa H., Kubota E., Saito K. Modulation of Fl cytotoxic potentials by GvHR: Role and mode of action of non-MHC genes that determine the hybrid resistance to GvHR-associated suppression of Fl cytotoxic potential. Immunol 1984; 132: 2165–2682
  • Fast L. D. DBA/2J and DBA/2Ha lymphocytes differ in their ability to induce graft-vs-host disease. J Immunol 1989; 143: 2489–2493
  • Portanova J. P., Ebling F. M., Hammond W. S., Hahn B. H., Kotzin B. L. Allogeneic MHC antigen requirements for lupus-like autoantibody production and nephritis in murine graft-versus-host disease. J Immunol 1988; 141: 3370–3376
  • Renal Disease. Classification and Atlas of Glomerular Disease, J. Churg. Igaku-shoin, Tokyo, New York 1982; 127–149
  • Pals S. T., Gleichmann H. Gleichmann Allosuppressor E. and allohelper T cells in acute and chronic graft-versus-host disease V. Fl mice with secondary chronic GVHD contain Fl-reactive allohelper but no allosuppressor T cells. Exp Med 1984; 159: 508–523

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.